These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7661067)

  • 1. Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation.
    Saxon LA; Wiener I; DeLurgio DB; Natterson PD; Laks H; Drinkwater DC; Stevenson WG
    Am Heart J; 1995 Sep; 130(3 Pt 1):501-6. PubMed ID: 7661067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy?
    Schmidinger H
    Am J Cardiol; 1999 Mar; 83(5B):151D-157D. PubMed ID: 10089858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
    Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.
    Gandjbakhch E; Rovani M; Varnous S; Maupain C; Chastre T; Waintraub X; Pousset F; Lebreton G; Duthoit G; Badenco N; Himbert C; Leprince P; Hidden-Lucet F
    Arch Cardiovasc Dis; 2016; 109(8-9):476-85. PubMed ID: 27344378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation.
    Sandner SE; Wieselthaler G; Zuckermann A; Taghavi S; Schmidinger H; Pacher R; Ploner M; Laufer G; Wolner E; Grimm M
    Circulation; 2001 Sep; 104(12 Suppl 1):I171-6. PubMed ID: 11568051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation.
    Sweeney MO; Ruskin JN; Garan H; McGovern BA; Guy ML; Torchiana DF; Vlahakes GJ; Newell JB; Semigran MJ; Dec GW
    Circulation; 1995 Dec; 92(11):3273-81. PubMed ID: 7586314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator and wait-list outcomes in pediatric patients awaiting heart transplantation.
    El-Assaad I; Al-Kindi SG; Oliveira GH; Boyle GJ; Aziz PF
    Heart Rhythm; 2015 Dec; 12(12):2443-8. PubMed ID: 26247317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication.
    Saba S; Atiga WL; Barrington W; Ganz LI; Kormos RL; MacGowan GA; Mathier MA; McNamara DM; Obioha-Ngwu O; Murali S
    J Heart Lung Transplant; 2003 Apr; 22(4):411-8. PubMed ID: 12681418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation.
    Da Rosa MR; Sapp JL; Howlett JG; Falkenham A; Légaré JF
    J Heart Lung Transplant; 2007 Dec; 26(12):1336-9. PubMed ID: 18096488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation.
    Grimm M; Wieselthaler G; Avanessian R; Grimm G; Schmidinger H; Schreiner W; Podczeck A; Wolner E; Laufer G
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):532-9. PubMed ID: 7637372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial.
    Aoukar PS; Poole JE; Johnson GW; Anderson J; Hellkamp AS; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2013 Jul; 10(7):970-6. PubMed ID: 23562699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICD therapy in survivors of sudden cardiac death awaiting heart transplantation.
    Grimm M; Grimm G; Zuckermann A; Wieselthaler G; Feuerstein M; Daneschvar H; Schmiedinger H; Schreiner W; Wolner E; Laufer G
    Ann Thorac Surg; 1995 Apr; 59(4):916-20. PubMed ID: 7695418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrillator implantation for the primary prevention of sudden death in patients awaiting cardiac transplantation: one center's experience.
    Bastante Valiente T; Cano MJ; Delgado JF; Gil ML; Arribas F; Sánchez MA; Cortina J; Sáenz de la Calzada C
    Rev Esp Cardiol; 2011 Mar; 64(3):240-2. PubMed ID: 21315501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M; Wan C; Singh V; Salehi N; Ahmad J; Szymkiewicz SJ; Thakur RK
    J Heart Lung Transplant; 2015 Oct; 34(10):1305-9. PubMed ID: 26094085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V; Perault R; Bories MC; Narayanan K; Garcia R; Combes N; Perier MC; Defaye P; Sadoul N; Gras D; Klug D; Bordachar P; Fauchier L; Deharo JC; Leclercq C; Boveda S; Marijon E; Babuty D;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):758-765. PubMed ID: 30078651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator.
    Fonarow GC; Feliciano Z; Boyle NG; Knight L; Woo MA; Moriguchi JD; Laks H; Wiener I
    Am J Cardiol; 2000 Apr; 85(8):981-5. PubMed ID: 10760339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of mortality in patients awaiting cardiac transplantation: increased risk of sudden death in ischemic compared to idiopathic dilated cardiomyopathy.
    Lavee J; Kormos RL; Uretsky BF; Murali S; Donato W; Hardesty RL; Griffith BP
    Isr J Med Sci; 1996 May; 32(5):282-7. PubMed ID: 8641864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.